Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia

Juvenile myelomonocytic leukemia (JMML) treatment primarily relies on hematopoietic stem cell transplantation and results in long-term overall survival of 50–60%, demonstrating a need to develop novel treatments. Dysregulation of the non-coding RNA transcriptome has been demonstrated before in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofmans, Mattias, Lammens, Tim, Depreter, Barbara, Wu, Ying, Erlacher, Miriam, Caye, Aurélie, Cavé, Hélène, Flotho, Christian, de Haas, Valerie, Niemeyer, Charlotte M., Stary, Jan, Van Nieuwerburgh, Filip, Deforce, Dieter, Van Loocke, Wouter, Van Vlierberghe, Pieter, Philippé, Jan, De Moerloose, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854679/
https://www.ncbi.nlm.nih.gov/pubmed/33531590
http://dx.doi.org/10.1038/s41598-021-82509-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854679/
https://www.ncbi.nlm.nih.gov/pubmed/33531590
http://dx.doi.org/10.1038/s41598-021-82509-5

Ejemplares similares